Primary Navigation for the CDC Web Site
CDC en Español
Cancer Prevention and Control
divider
E-Mail Icon E-mail this page
Printer Friendly Icon Printer-friendly version
divider
 View by Topic
bullet About Us
bullet Resource Library
bullet Publications Available Online
bullet Print Publication Ordering System
bullet Scientific Articles
bullet Comprehensive Cancer Control Plans Search
bullet Preventive Cancer Screening
bullet Program Contacts
bullet Partners
bullet Data
bullet Newsroom
bullet Site Map

Contact Information Centers for Disease
Control and Prevention
Division of Cancer
Prevention and Control
4770 Buford Hwy, NE
MS K-64
Atlanta, GA 30341-3717

Call: 1 (800) CDC-INFO
TTY: 1 (888) 232-6348
FAX: (770) 488-4760

E-mail: cdcinfo@cdc.gov

Submit a Question Online

Fiscal Year 2004 Scientific Articles

Return to index

This page contains a list of citations for selected publications authored by CDC's Division of Cancer Prevention and Control (DCPC) staff members, during the period of October 1, 2003 to September 30, 2004. The list of citations is organized alphabetically into specific cancer topic areas.

  • Breast Cancer
  • Cancer Survivorship
  • Cervical Cancer
  • Colorectal Cancer
  • Health Disparities in Cancer
  • National Breast and Cervical Cancer Early Detection Program
  • National Program of Cancer Registries
  • Ovarian Cancer
  • Prostate Cancer
  • Skin Cancer
  • General and Miscellaneous

  • Breast Cancer

    Bobo JK, Shapiro JA, Schulman J, Wolters CL. On-schedule mammography rescreening in the National Breast and Cervical Cancer Early Detection Program.* Cancer Epidemiology, Biomarkers and Prevention 2004;13(4):620–630.

    Coughlin SS, Uhler RJ, Bobo JK, Caplan L. Breast cancer screening practices among women in the United States, 2000. Cancer Causes and Control 2004;15(2):159–170.

    Coughlin SS, Uhler RJ, Hall HI, Briss PA. Nonadherence to breast and cervical cancer screening: What are the linkages to chronic disease risk? Preventing Chronic Disease 2004;1(1):1–20.

    Daling JR, Malone KE, Doody DR, Voigt LF, Bernstein L, Marchbanks PA, Coates RJ, Norman SA, Weiss LK, Ursin G, Burkman RT, Deapen D, Folger SG, McDonald JA, Simon MS, Strom BL, Spirtas R. Association of regimens of hormone replacement therapy to prognostic factors among women diagnosed with breast cancer aged 50–64 years.* Cancer Epidemiology, Biomarkers and Prevention 2003(11);12:1175–1181.

    French C, True S, McIntyre R, Sciulli M, Maloy K. State implementation of the Breast and Cervical Cancer Prevention and Treatment Act of 2000: A collaborative effort among government agencies. Public Health Reports 2004;119(3):279–285.

    Gwyn K, Bondy ML, Cohen DS, Lund MJ, Liff JM, Flagg EW, Brinton LA, Eley JW, Coates RJ. Racial differences in diagnosis, treatment, and clinical delays in a population-based study of patients with newly diagnosed breast carcinoma. Cancer 2004;100(8):1595–1604.

    Hall HI, Jamison PM, Coughlin SS. Breast and cervical cancer mortality in the Mississippi Delta, 1979–1998. Southern Medical Journal 2004;97(3):264–272.

    Hall HI, Jamison PM, Coughlin SS, Uhler RJ. Breast and cervical cancer screening among Mississippi Delta women. Journal of Health Care for the Poor and Underserved 2004;15(3):375–389.

    Hutton BJ, Bradt EK, Chen JH, Gobrecht P, O'Connell J, Pedulla A, Signorelli T, Bisner S, Hoffman DP, Lawson HW. Breast cancer-screening data for assessing quality of services—New York State, 2000–2003. MMWR 2004;53(21):455–457.

    Jacobellis J, Martin L, VanEenwyk J, Bradley LA, Kassim S, Jorgensen C, Litch JA, Myers MF. Genetic testing for breast and ovarian cancer susceptibility: Evaluating direct-to-consumer marketing—Atlanta, Denver, Raleigh-Durham, and Seattle, 2003. MMWR 2004;53(27):603–606.

    Norman SA, Berlin JA, Weber AL, Strom BL, Daling JR, Weiss LK, Marchbanks PA, Bernstein L, Voigt LF, McDonald JA, Ursin G, Liff JM, Burkman RT, Malone KE, Simon MS, Folger SG, Deapen D, Wingo PA, Spirtas R. Combined effect of oral contraceptive use and hormone replacement therapy on breast cancer risk in postmenopausal women. Cancer Causes and Control 2003;14(10):933–943.

    Porter PL, Lund MJ, Lin MG, Yuan X, Liff JM, Flagg EW, Coates RJ, Eley JW. Racial differences in the expression of cell cycle-regulatory proteins in breast carcinoma: Study of young African-American and white women in Atlanta, Georgia. Cancer 2004;100(12):2533–2542.

    Smith-Bindman R, Chu PW, Miglioretti DL, Sickles EA, Blanks R, Ballard-Barbash R, Bobo JK, Lee NC, Wallis MG, Patnick J, Kerlikowske K. Comparison of screening mammography in the United States and the United Kingdom.* Journal of the American Medical Association 2003;290(16):2129–2137.

    Whiteman MK, Hillis SD, Curtis KM, McDonald JA, Wingo PA, Marchbanks PA. Reproductive history and mortality after breast cancer diagnosis.* Obstetrics and Gynecology 2004;104(1):146–154.

    Wingo PA, Cardinez C, Landis SH, Greenlee R, Anderson RN, Ries LAG, Thun MJ. Long-term trends in cancer mortality in the United States, 1930–1998. Cancer 2003;97(12 Suppl):3133–3275.

    Wingo PA, Jamison PM, Young JL, Gargiullo P. Population-based statistics for women diagnosed with inflammatory breast cancer (United States). Cancer Causes and Control 2004;15(3):321–328.

    Young Jr JL, Ward KC, Wingo PA, Howe HL. The incidence of malignant non-carcinomas of the female breast. Cancer Causes and Control 2004;15(3):313–319.

    Cancer Survivorship

    Brown JK, Byres T, Doyle C, Courneya KS, Demark-Wahnefried W, Kushi LH, McTiernan, Rock CL, Aziz N, Bloch AS, Elridge, Hamilton K, Katzin C, Koonce A, Main J, Mobley C, Morra ME, Peirce MS, Sawyer KA. Nutrition and physical activity during and after cancer treatment: An American Cancer Society guide for informed choices.* CA: A Cancer Journal for Clinicians 2003;53(5):268–286.

    Jemal A, Clegg LX, Ward E, Ries LA, Wu X, Jamison PM, Wingo PA, Howe HL, Anderson RN, Edwards BK. Annual report to the nation on the status of cancer, 1975–2001, with a special feature regarding survival. Cancer 2004;101(1):3–27.

    Rowland J, Mariotto A, Aziz N, Tesauro G, Feuer EJ, Blackman D, Thompson P, Pollack LA. Cancer survivorship—United States, 1971–2001. MMWR 2004;53(24):526–529.

    Cervical Cancer

    Benard VB, Eheman CR, Lawson HW, Blackman DK, Anderson C, Helsel W, Thames SF, Lee NC. Cervical screening in the National Breast and Cervical Cancer Early Detection Program, 1995–2001.* Obstetrics and Gynecology 2004;103(3):564–571.

    Berg GD, Chattopadhyay SK. Determinants of hospital length of stay for cervical dysplasia and cervical cancer: Does managed care matter? The American Journal of Managed Care 2004;10(1):33–38.

    Coughlin SS, Uhler RJ, Hall HI, Briss PA. Nonadherence to breast and cervical cancer screening: What are the linkages to chronic disease risk? Preventing Chronic Disease 2004;1(1):1–20.

    French C, True S, McIntyre R, Sciulli M, Maloy K. State implementation of the Breast and Cervical Cancer Prevention and Treatment Act of 2000: A collaborative effort among government agencies. Public Health Reports 2004;119(3):279–285.

    Hall HI, Jamison PM, Coughlin SS. Breast and cervical cancer mortality in the Mississippi Delta, 1979–1998. Southern Medical Journal 2004;97(3):264–272.

    Hall HI, Jamison PM, Coughlin SS, Uhler RJ. Breast and cervical cancer screening among Mississippi Delta women. Journal of Health Care for the Poor and Underserved 2004;15(3):375–389.

    Sawaya GF, McConnell KJ, Kulasingam SL, Lawson HW, Kerlikowske K, Melnikow J, Lee NC, Gildengorin G, Myers ER, Washington AE. Risk of cervical cancer associated with extending the interval between cervical-cancer screenings. New England Journal of Medicine 2003;349(16):1501–1509.

    Sawaya G, Kulasingam S, Lawson H. Risk of cervical cancer associated with extending screening intervals in well-screened women—letter response. New England Journal of Medicine 2004;330:414–415.

    Wingo PA, Cardinez C, Landis SH, Greenlee R, Anderson RN, Ries LAG, Thun MJ. Long-term trends in cancer mortality in the United States, 1930–1998. Cancer 2003;97(12 Suppl):3133–3275.

    Colorectal Cancer

    Armour BS, Friedman C, Pitts MM, Wike J, Alley L, Etchason J. The influence of year-end bonuses on colorectal cancer screening. The American Journal of Managed Care 2004;10(9):617–624.

    Cooper CP, Williams KN, Carey KA, Fowler CS, Frank M, Gelb CA. Advertising campaign on a major Internet search engine to promote colorectal cancer screening. British Medical Journal 2004;328(7449):1179–1180.

    Coughlin SS, Thompson TD. Colorectal cancer screening practices among men and women in rural and nonrural areas of the United States, 1999. The Journal of Rural Health 2004;20(2):118–124.

    Montano DE, Selby JV, Somkin CP, Bhat A, Nadel M. Acceptance of flexible sigmoidoscopy screening for colorectal cancer. Cancer Detection and Prevention 2004;28(1):43–51.

    Seeff LC, Nadel MR, Klabunde CN, Thompson T, Shapiro JA, Vernon SW, Coates RJ. Patterns and predictors of colorectal cancer test use in the adult U.S. population. Cancer 2004;100(10):2093–2103.

    Vernon SW, Meissner H, Klabunde C, Rimer BK, Ahnen DJ, Bastani R, Mandelson MT, Nadel MR, Sheinfeld-Gorin S, Zapka J. Measures for ascertaining use of colorectal cancer screening in behavioral, health services, and epidemiologic research.* Cancer Epidemiology, Biomarkers and Prevention 2004;13(6):898–905.

    Williams KW. Centers for Disease Control and Prevention. Notice to Readers: National Colorectal Cancer Awareness Month. MMWR 2004;53(10):221.

    Health Disparities in Cancer

    Brown JK, Byres T, Doyle C, Courneya KS, Demark-Wahnefried W, Kushi LH, McTiernan, Rock CL, Aziz N, Bloch AS, Elridge, Hamilton K, Katzin C, Koonce A, Main J, Mobley C, Morra ME, Peirce MS, Sawyer KA. Nutrition and physical activity during and after cancer treatment: An American Cancer Society guide for informed choices.* CA: A Cancer Journal for Clinicians 2003;53(5):268–286.

    Cooper CP, Jorgensen CM, Merritt TL. Telephone focus groups: An emerging method in public health research. Journal of Women's Health 2003;12(10):945–951.

    Coughlin SS, Calle EE, Teras LR, Petrelli J, Thun MJ. Diabetes mellitus as a predictor of cancer mortality in a large cohort of U.S. adults. American Journal of Epidemiology 2004;159(12):1160–1167.

    Coughlin SS, Thompson TD. Colorectal cancer screening practices among men and women in rural and nonrural areas of the United States, 1999. The Journal of Rural Health 2004;20(2):118–124.

    Glasgow RE, Marcus AC, Bull SS, Wilson KM. Disseminating effective cancer screening interventions. Cancer 2004;101(5 Suppl):1239–1250.

    Grant DJ, Hall IJ, Eastmond DA, Jones IM, Bell DA. Bilirubin UDP-glucuronosyltransferase 1A1 (UGT1A1) gene promoter polymorphisms and HPRT, glycophorin A, and micronuclei mutant frequencies in human blood. Mutation Research/Genetic Toxicology and Environmental Mutagenesis 2004;560(1):1–10.

    Gwyn K, Bondy ML, Cohen DS, Lund MJ, Liff JM, Flagg EW, Brinton LA, Eley JW, Coates RJ. Racial differences in diagnosis, treatment, and clinical delays in a population-based study of patients with newly diagnosed breast carcinoma. Cancer 2004;100(8):1595–1604.

    Hall HI, Jamison PM, Coughlin SS. Breast and cervical cancer mortality in the Mississippi Delta, 1979–1998. Southern Medical Journal 2004;97(3):264–272.

    Hall HI, Jamison PM, Coughlin SS, Uhler RJ. Breast and cervical cancer screening among Mississippi Delta women. Journal of Health Care for the Poor and Underserved 2004;15(3):375–389.

    Jemal A, Clegg LX, Ries LAG, Wu X, Jamison PM, Wingo PA, Howe HL, Anderson RN, Edwards BK. Annual report to the nation on the status of cancer, 1975–2001, with a special feature regarding survival. Cancer 2004;101(1):3–27.

    Meissner HI, Smith RA, Rimer BK, Wilson KM, Rakowski W, Vernon SW, Briss PA. Promoting cancer screening: Learning from experience. Cancer 2004;101(5 Suppl):1107–1117.

    Meissner HI, Vernon SW, Rimer BK, Wilson KM, Rakowski W, Briss PA, Smith RA. The future of research that promotes cancer screening. Cancer 2004;101(5 Suppl):1251–1259.

    Porter PL, Lund MJ, Lin MG, Yuan X, Liff JM, Flagg EW, Coates RJ, Eley JW. Racial differences in the expression of cell cycle-regulatory proteins in breast carcinoma: Study of young African-American and white women in Atlanta, Georgia. Cancer 2004;100(12):2533–2542.

    National Breast and Cervical Cancer Early Detection Program (NBCCEDP)

    Bobo JK, Shapiro JA, Schulman J, Wolters CL. On-schedule mammography rescreening in the National Breast and Cervical Cancer Early Detection Program.* Cancer Epidemiology, Biomarkers and Prevention 2004;13(4):620–630.

    National Program of Cancer Registries (NPCR)

    CDC, the Council of State and Territorial Epidemiologists, and the Association of State and Territorial Chronic Disease Program Directors. Indicators for chronic disease surveillance. MMWR 2004;53(RR11):1–6.

    Hall HI, Jamison PM, Fulton JP, Clutter G, Roffers S, Parrish P. Reporting cutaneous melanoma to cancer registries in the United States. Journal of the American Academy of Dermatology 2003;49(4):624–630.

    Jemal A, Clegg LX, Ward E, Ries LA, Wu X, Jamison PM, Wingo PA, Howe HL, Anderson RN, Edwards BK. Annual report to the nation on the status of cancer, 1975–2001, with a special feature regarding survival. Cancer 2004;101(1):3–27.

    Stewart SL, King JB, Thompson TD, Friedman C, Wingo PA. Cancer mortality surveillance—United States, 1990–2000. MMWR 2004;53(SS03):1–108.

    U.S. Cancer Statistics Working Group (Jamison P, Almon L, et al.). United States Cancer Statistics: 2000 Incidence. Atlanta (GA): Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute; 2003.

    Ovarian Cancer

    Jacobellis J, Martin L, VanEenwyk J, Bradley LA, Kassim S, Jorgensen C, Litch JA, Myers MF. Genetic testing for breast and ovarian cancer susceptibility: Evaluating direct-to-consumer marketing—Atlanta, Denver, Raleigh-Durham, and Seattle, 2003. MMWR 2004;53(27):603–606.

    Prostate Cancer

    Briss P, Rimer B, Reilley B, Coates RJ, Lee NC, Mullen P, Corso P, Hutchinson AB, Hiatt R, Kerner J, George P, White C, Gandhi N, Saraiya M, Breslow R, Isham G, Teutsch SM, Hinman AR, Lawrence R. Promoting informed decisions about cancer screening in communities and healthcare systems. American Journal of Preventive Medicine 2004;26(1):67–80.

    Cooper CP, Merritt TL, Ross LE, John LV, Jorgensen CM. To screen or not to screen, when clinical guidelines disagree: Primary care physicians' use of the PSA test. Preventive Medicine 2004;38(2):182–191.

    Hall HI, Van Den Eeden SK, Tolsma DD, Rardin K, Thompson T, Hughes SA, Madlon-Kay DJ, Nadel M. Testing for prostate and colorectal cancer: Comparison of self-report and medical record audit. Preventive Medicine 2004;39(1):27–35.

    Ross LE, Coates RJ, Breen N, Uhler RJ, Potosky AL, Blackman D. Prostate-specific antigen test use reported in the 2000 National Health Interview Survey. Preventive Medicine 2004;38(6):732–744.

    Tseng M, Breslow RA, DeVellis RF, Ziegler RG. Dietary patterns and prostate cancer risk in the National Health and Nutrition Examination Survey Epidemiological Follow-up Study Cohort.* Cancer Epidemiology, Biomarkers and Prevention 2004;13(1):71–77.

    Skin Cancer

    Hall HI, Saraiya M, Thompson T, Hartman A, Glanz K, Rimer B. Correlates of sunburn experiences among U.S. adults: Results of the 2000 National Health Interview Survey. Public Health Reports 2003;118(6):540–549.

    Saraiya M, Glanz K, Briss P, Nichols P, White C, Das D. Preventing skin cancer: Findings of the Task Force on Community Preventive Services on reducing exposure to ultraviolet light. MMWR Recommendations and Reports 2003;52(RR15):1–12.

    Saraiya M, Hall HI, Thompson T, Hartman A, Glanz K, Rimer B, Rose D. Skin cancer screening among U.S. adults from 1992, 1998, and 2000 National Health Interview Surveys. Preventive Medicine 2004;39(2):308–314.

    General and Miscellaneous

    Brown JK, Byres T, Doyle C, Courneya KS, Demark-Wahnefried W, Kushi LH, McTiernan, Rock CL, Aziz N, Bloch AS, Elridge, Hamilton K, Katzin C, Koonce A, Main J, Mobley C, Morra ME, Peirce MS, Sawyer KA. Nutrition and physical activity during and after cancer treatment: An American Cancer Society guide for informed choices.* CA: A Cancer Journal for Clinicians 2003;53(5):268–286.

    Cooper CP, Jorgensen CM, Merritt TL. Telephone focus groups: An emerging method in public health research. Journal of Women's Health 2003;12(10):945–951.

    Coughlin SS, Calle EE, Teras LR, Petrelli J, Thun MJ. Diabetes mellitus as a predictor of cancer mortality in a large cohort of U.S. adults. American Journal of Epidemiology 2004;159(12):1160–1167.

    Glasgow RE, Marcus AC, Bull SS, Wilson KM. Disseminating effective cancer screening interventions. Cancer 2004;101(5 Suppl):1239–1250.

    Grant DJ, Hall IJ, Eastmond DA, Jones IM, Bell DA. Bilirubin UDP-glucuronosyltransferase 1A1 (UGT1A1) gene promoter polymorphisms and HPRT, glycophorin A, and micronuclei mutant frequencies in human blood. Mutation Research/Genetic Toxicology and Environmental Mutagenesis 2004;560(1):1–10.

    Jemal A, Clegg LX, Ward E, Ries LA, Wu X, Jamison PM, Wingo PA, Howe HL, Anderson RN, Edwards BK. Annual report to the nation on the status of cancer, 1975–2001, with a special feature regarding survival. Cancer 2004;101(1):3–27.

    Meissner HI, Smith RA, Rimer BK, Wilson KM, Rakowski W, Vernon SW, Briss PA. Promoting cancer screening: Learning from experience. Cancer 2004;101(5 Suppl):1107–1117.

    Meissner HI, Vernon SW, Rimer BK, Wilson KM, Rakowski W, Briss PA, Smith RA. The future of research that promotes cancer screening. Cancer 2004;101(5 Suppl):1251–1259.

    *Links to non-Federal organizations found at this site are provided solely as a service to our users. These links do not constitute an endorsement of these organizations or their programs by CDC or the Federal Government, and none should be inferred. CDC is not responsible for the content of the individual organization Web pages found at these links.

    Page last reviewed: August 6, 2008
    Page last updated: August 6, 2008
    Content source: Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion
      Home | Policies and Regulations | Disclaimer | e-Government | FOIA | Contact Us
    Safer, Healthier People

    Centers for Disease Control and Prevention
    1600 Clifton Rd, Atlanta, GA 30333, U.S.A.
    800-CDC-INFO (800-232-4636) TTY: (888) 232-6348, 24 Hours/Every Day - cdcinfo@cdc.gov
    USA.govDHHS Department of Health
    and Human Services